Corona Vaccine Distribution: Hopes and Facts


In record time, 18 Corona vaccines have reached the testing stage and five have already hit the market for initial or limited use. Recently, Pfizer Bio-Tech and Moderna have been trying to get ahead of each other in the race to distribute vaccines. 64 vaccines are in the clinical trial phase and 85 animals are in the testing phase. The world was not ready in the early years of the plague but as the market is being filled with vaccines the question is whether the world is ready for the distribution phase. ۔

The vaccine is currently available in limited quantities. Therefore, health experts around the world are setting their own priorities for the vaccine. The World Health Organization's priorities include health workers, the elderly and people suffering from a variety of serious illnesses. Although US officials acknowledge that Department of Health employees, nursing homes and caregivers are leading the way in obtaining vaccines, the impartiality of the distribution process is being questioned.

Some human rights activists have expressed concern about racial discrimination in its distribution, and have indicated that ethnic minorities will be overlooked in this process of prioritization. Similarly, if the first priority is given to those who work instead of the elderly, then the most vulnerable African American seniors will be ignored. Similarly, Asians, Hispanics and Native Americans have higher mortality rates than whites and need vaccines first.

Similarly, minorities who do not have equal access to health care and are involved in jobs that now involve the public are also more likely to be affected by Corona and should be included in Corona's priorities. ۔ The UK faces similar problems. There, too, minority groups are the biggest victims of the Karuna epidemic. 

Black Africans have a much higher mortality rate than whites. On the one hand, their lives are in grave danger, but on the other hand, they are also afraid of using this vaccine that no experiments are being done on them. According to a recent survey, 39% of London's racist minorities have a positive view of vaccine use, compared to 70% of whites.

At the same time, such suspicions have been fueled by ongoing anti-vaccination movements. According to the London-based Center for Digital Hate, anti-vaccine elements have strengthened their presence on social media and on various civil media sites. The number of his followers has reached 8 million. In addition, amid a heated debate over the need for a vaccine, a tweet from a Brazilian politician has sparked a new debate. 

Roberto Jefferson, a former member of Congress and a supporter of the president, said in a tweet that global experts were developing vaccines to change our genetic material. His tweet has been fueled by anti-vaccine elements.

In addition, the distribution process faces transportation problems. The UK, which is set to vaccinate 25 million people in 2021, also faces transportation problems. Because this vaccine is not a magically dilute drug that can be easily absorbed, there are serious challenges to its delivery that are not yet being considered. 

At a time when humanity has been using vaccines for a decade, the supply chain is not ready for the current vaccine epidemic crisis. First, the vaccine requires a large amount of accessories, protective equipment, syringes, needles, rubber gloves and alcohol swabs. Brazil is already short of syringes and vials. Second, the vaccine should be stored according to its set order and the required temperature. 

Once melted, the fire vaccine cannot last more than five days. On the other hand, if stored in the refrigerator, the Moderna vaccine can last a month and has a lifespan of only 12 hours at room temperature. Pfizer vaccines can be stored in regular refrigerators, while Moderna must be stored at minus 70 degrees, so securing them is no less of a challenge.

Third, ignoring others and focusing on one's illness can lead to serious problems in developing countries. Mozambique and Thailand have faced similar problems in the past. And last but not least, the real fear is that the vaccine will only be delivered to rich and developed countries. During the H1N1 epidemic in 2009, developed countries acquired all stocks of the vaccine. If history repeats itself and the need for this vaccine from the world, it can be said that poor countries will have to wait for years.

The distribution process is still complicated and no preparations have been made for the supply of vaccines. And it has not yet been decided who and how the distribution process will begin. In short, all people are equal, but some people are a little more equal. Therefore, the supply of vaccines will face ethical, medical, transportation and other issues.

Post a Comment